Peter Bugert
Overview
Explore the profile of Peter Bugert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
2830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Uzun G, Singh A, Abou-Khalel W, Pelzl L, Weich K, Nowak-Harnau S, et al.
Hamostaseologie
. 2022 Oct;
42(S 01):S14-S23.
PMID: 36288732
Coronavirus disease-2019 (COVID-19) is associated with increased thromboembolic complications. Long-term alteration in coagulation system after acute COVID-19 infection is still a subject of research. Furthermore, the effect of sera from...
12.
Eiseler K, Dropmann L, Bugert P, Ewers M, Witt H
Pancreatology
. 2022 Sep;
22(8):1079-1083.
PMID: 36167651
Background: Alterations in genes specifically expressed in the pancreas have been associated with chronic pancreatitis (CP). A significant percentage of patients with non-alcoholic CP, however, do not have mutations in...
13.
Willer H, Spohn G, Morgenroth K, Thielemann C, Elvers-Hornung S, Bugert P, et al.
Front Immunol
. 2022 Sep;
13:976511.
PMID: 36059533
Human Mesenchymal Stromal Cells (hMSCs) are a promising source for cell-based therapies. Yet, transition to phase III and IV clinical trials is remarkably slow. To mitigate donor variabilities and to...
14.
Muller R, Rink G, Uzun G, Bakchoul T, Wuchter P, Kluter H, et al.
Thromb Res
. 2022 Jul;
216:120-124.
PMID: 35810548
Background: The coronavirus disease-2019 (COVID-19) is a systemic disease with severe implications on the vascular and coagulation system. A procoagulant platelet phenotype has been reported at least in the acute...
15.
Toth A, Demcsak A, Zankl F, Oracz G, Unger L, Bugert P, et al.
Pancreatology
. 2022 Jun;
22(6):713-718.
PMID: 35773178
Background: Genetic alterations in digestive enzymes have been associated with chronic pancreatitis (CP). Recently, chymotrypsin like elastase 3B (CELA3B) emerged as a novel risk gene. Thus, we evaluated CELA3B in...
16.
Rygiel A, Unger L, Sorgel F, Masson E, Matsumoto R, Ewers M, et al.
Pancreatology
. 2022 May;
22(5):564-571.
PMID: 35589511
Objective: Non-alcoholic chronic pancreatitis (NACP) frequently develops in the setting of genetic susceptibility associated with alterations in genes that are highly expressed in the pancreas. However, the genetic basis of...
17.
Ewers M, Epple D, Bugert P, Rosendahl J, Witt H
Pancreatology
. 2022 Jan;
22(2):244-247.
PMID: 35031208
Background: Genetic mutations in various pancreatic enzymes or their counteracting proteins have been linked to chronic pancreatitis. In particular, variants in the genes encoding pancreatic lipase (PNLIP) and carboxyl ester...
18.
Ewers M, Canaff L, Weh A, Masson E, Eiseler K, Chen J, et al.
Pancreatology
. 2021 Aug;
21(7):1299-1304.
PMID: 34446336
Background: The calcium sensing receptor (CASR) is a G protein-coupled receptor that is responsible for assessing extracellular Ca levels and thus plays a crucial role in calcium homeostasis. Hypercalcemia is...
19.
Clausen F, Hellberg A, Bein G, Bugert P, Schwartz D, Dovc Drnovsek T, et al.
Vox Sang
. 2021 Jun;
117(2):157-165.
PMID: 34155647
Background And Objectives: Non-invasive assays for predicting foetal blood group status in pregnancy serve as valuable clinical tools in the management of pregnancies at risk of detrimental consequences due to...
20.
Naumann N, Lubke J, Baumann S, Schwaab J, Hoffmann O, Kreil S, et al.
Int J Mol Sci
. 2021 Apr;
22(5).
PMID: 33806359
In systemic mastocytosis (SM), qualitative and serial quantitative assessment of the D816V mutation is of diagnostic and prognostic relevance. We investigated peripheral blood and bone marrow samples of 161 patients...